Hsbc Holdings PLC Supernus Pharmaceuticals, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 250,364 shares of SUPN stock, worth $9.31 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250,364

Previous 14,010 1687.04%

Holding current value

$9.31 Million

Previous $374,000 1987.17%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$25.77 - $35.16 $6.09 Million - $8.31 Million	236,354 Added 1687.04%	250,364 $7.81 Million
Q2 2024 Aug 12, 2024	SELL	$25.99 - $33.85 $4.51 Million - $5.87 Million	-173,394 Reduced 92.52%	14,010 $374,000
Q1 2024 May 15, 2024	BUY	$27.11 - $35.17 $4.8 Million - $6.23 Million	177,103 Added 1719.28%	187,404 $6.39 Million
Q4 2023 Feb 12, 2024	SELL	$22.72 - $29.68 $69,591 - $90,909	-3,063 Reduced 22.92%	10,301 $298,000
Q3 2023 Nov 13, 2023	SELL	$27.57 - $32.91 $373,656 - $446,029	-13,553 Reduced 50.35%	13,364 $368,000
Q2 2023 Aug 11, 2023	BUY	$29.91 - $38.73 $191,573 - $248,065	6,405 Added 31.23%	26,917 $809,000
Q1 2023 May 15, 2023	SELL	$34.93 - $42.03 $238,152 - $286,560	-6,818 Reduced 24.95%	20,512 $743,000
Q4 2022 Feb 14, 2023	BUY	$31.09 - $37.88 $128,526 - $156,595	4,134 Added 17.82%	27,330 $974,000
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $153,853 - $189,231	5,344 Added 29.94%	23,196 $791,000
Q2 2022 Aug 11, 2022	BUY	$25.33 - $34.25 $21,809 - $29,489	861 Added 5.07%	17,852 $512,000
Q1 2022 May 16, 2022	BUY	$28.51 - $32.9 $484,413 - $559,003	16,991 New	16,991 $550,000
Q3 2021 Nov 12, 2021	SELL	$23.54 - $31.39 $182,623 - $243,523	-7,758 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$26.72 - $33.19 $207,293 - $257,488	7,758 New	7,758 $238,000
Q4 2020 Feb 12, 2021	SELL	$17.7 - $25.81 $267,464 - $390,014	-15,111 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$20.2 - $25.05 $305,242 - $378,530	15,111 New	15,111 $318,000
Q2 2018 Aug 10, 2018	SELL	$44.1 - $59.85 $2.28 Million - $3.09 Million	-51,590 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$37.15 - $46.9 $1.92 Million - $2.42 Million	51,590 New	51,590 $2.36 Million

Others Institutions Holding SUPN

# of Institutions

281

Shares Held

60.6M

Call Options Held

27.7K

Put Options Held

11.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.99B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Supernus Pharmaceuticals, Inc. Transaction History